Saballa, Ma. Rizelle S.
HRN: 26-24-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2024
CEFUROXIME 500MG (TAB)
11/17/2024
11/23/2024
PO
500 Mg
BID
SP RMLE
Waiting Final Action